Ascendis Pharma A/S (ASND) Stock: Charts & Financials

Ascendis Pharma A/S(ASND)

Biotechnology · Hellerup, CR

$228.03+0.16 (+0.07%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.

Hellerup, CR

1,189 employees

ascendispharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jan Moller Mikkelsen

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	1.59B	1.59B	1.30B	1.30B	1.19B	1.12B	996.56M	1.10B	1.08B
Cash & Cash Equivalents	927.36M	927.36M	662.48M	723.29M	632.55M	582.32M	560.12M	579.40M	696.48M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	927.36M	927.36M	662.48M	723.29M	632.55M	582.32M	560.12M	579.40M	696.48M
Accounts Receivable	255.86M	255.86M	227.38M	185.15M	172.78M	130.19M	72.12M	172.18M	36.85M
Inventory	354.59M	354.59M	363.54M	354.03M	354.38M	357.59M	316.95M	306.10M	295.55M
Total Assets	2.61B	2.61B	2.32B	1.53B	1.35B	1.28B	1.15B	1.22B	1.22B
Property, Plant & Equipment	154.91M	154.91M	157.19M	171.98M	119.41M	110.26M	99.98M	102.22M	108.59M
Goodwill	0.00	0.00	4.27M	4.10M	0.00	0.00	0.00	3.62M	0.00
Intangible Assets	4.20M	4.20M	0.00	252K	4.39M	4.47M	4.23M	552K	4.57M
Long-Term Investments	65.04M	65.04M	58.90M	50.95M	33.21M	41.14M	44.27M	14.06M	18.05M
Total Current Liabilities	530.77M	530.77M	1.30B	1.26B	1.16B	1.10B	957.65M	940.08M	933.58M
Accounts Payable	118.65M	118.65M	90.89M	106.44M	92.23M	110.46M	91.24M	99.82M	83.81M
Short-Term Debt	74.70M	74.70M	590.47M	571.23M	565.89M	544.96M	529.88M	508.98M	500.75M
Total Liabilities	969.91M	969.91M	1.75B	1.72B	1.56B	1.50B	1.35B	1.33B	1.33B
Long-Term Debt	439.15M	439.15M	446.54M	452.32M	388.82M	389.18M	386.42M	378.04M	377.38M
Total Debt	513.85M	513.85M	1.04B	1.02B	954.70M	934.14M	916.30M	887.02M	878.14M
Net Debt (Cash)	-413.51M	-413.51M	374.53M	300.27M	322.16M	351.82M	356.18M	307.62M	181.66M
Total Shareholders' Equity	1.64B	1.64B	564.35M	-191.17M	-204.25M	-221.09M	-205.27M	-109.46M	-108.36M
Common Stock	10.14M	10.14M	9.69M	9.77M	9.72M	9.68M	8.85M	8.44M	9.07M
Retained Earnings	-2.14B	-2.14B	-2.41B	-3.17B	-3.17B	-3.14B	-2.87B	-2.65B	-2.84B
Current Ratio	2.99	2.99	1.00	1.04	1.03	1.02	1.04	1.17	1.16
Debt to Equity Ratio	0.31	0.31	1.84	N/A	N/A	N/A	N/A	N/A	N/A

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

1.59B

1.30B

1.19B

1.12B

996.56M

1.10B

1.08B

Cash & Cash Equivalents

927.36M

662.48M

723.29M

632.55M

582.32M

560.12M

579.40M

696.48M

Short-Term Investments

0.00

Cash & Short-Term Investments

927.36M

662.48M

723.29M

632.55M

582.32M

560.12M

579.40M

696.48M

Accounts Receivable

255.86M

227.38M

185.15M

172.78M

130.19M

72.12M

172.18M

36.85M

Inventory

354.59M

363.54M

354.03M

354.38M

357.59M

316.95M

306.10M

295.55M

Total Assets

2.61B

2.32B

1.53B

1.35B

1.28B

1.15B

1.22B

Property, Plant & Equipment

154.91M

157.19M

171.98M

119.41M

110.26M

99.98M

102.22M

108.59M

Goodwill

0.00

4.27M

4.10M

0.00

3.62M

0.00

Intangible Assets

4.20M

0.00

252K

4.39M

4.47M

4.23M

552K

4.57M

Long-Term Investments

65.04M

58.90M

50.95M

33.21M

41.14M

44.27M

14.06M

18.05M

Total Current Liabilities

530.77M

1.30B

1.26B

1.16B

1.10B

957.65M

940.08M

933.58M

Accounts Payable

118.65M

90.89M

106.44M

92.23M

110.46M

91.24M

99.82M

83.81M

Short-Term Debt

74.70M

590.47M

571.23M

565.89M

544.96M

529.88M

508.98M

500.75M

Total Liabilities

969.91M

1.75B

1.72B

1.56B

1.50B

1.35B

1.33B

Long-Term Debt

439.15M

446.54M

452.32M

388.82M

389.18M

386.42M

378.04M

377.38M

Total Debt

513.85M

1.04B

1.02B

954.70M

934.14M

916.30M

887.02M

878.14M

Net Debt (Cash)

-413.51M

374.53M

300.27M

322.16M

351.82M

356.18M

307.62M

181.66M

Total Shareholders' Equity

1.64B

564.35M

-191.17M

-204.25M

-221.09M

-205.27M

-109.46M

-108.36M

Common Stock

10.14M

9.69M

9.77M

9.72M

9.68M

8.85M

8.44M

9.07M

Retained Earnings

-2.14B

-2.41B

-3.17B

-3.14B

-2.87B

-2.65B

-2.84B

Current Ratio

2.99

1.00

1.04

1.03

1.02

1.04

1.17

1.16

Debt to Equity Ratio

0.31

1.84

N/A

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	1.30B	1.10B	775.63M	988.06M	917.38M	904.12M	685.87M	335.23M
Cash & Cash Equivalents	723.29M	579.40M	432.85M	475.87M	508.01M	714.03M	671.21M	318.01M
Short-Term Investments	0.00	0.00	8.03M	311.02M	268.42M	164.03M	0.00	0.00
Cash & Short-Term Investments	723.29M	579.40M	440.88M	786.89M	776.43M	878.06M	671.21M	318.01M
Accounts Receivable	185.15M	172.18M	39.60M	12.74M	2.50M	473K	902K	7K
Inventory	354.03M	306.10M	230.61M	139.81M	85.84M	0.00	0.00	0.00
Total Assets	1.53B	1.22B	911.24M	1.17B	1.24B	1.20B	759.45M	365.05M
Property, Plant & Equipment	171.98M	102.22M	122.11M	138.12M	143.49M	132.07M	50.58M	4.95M
Goodwill	4.10M	3.62M	3.86M	3.74M	3.98M	4.27M	3.92M	4.00M
Intangible Assets	252K	552K	1.02M	1.43M	2.02M	2.71M	0.00	0.00
Long-Term Investments	50.95M	14.06M	6.28M	32.55M	166.09M	152.03M	17.44M	19.55M
Total Current Liabilities	1.26B	940.08M	812.92M	766.91M	114.24M	64.50M	53.86M	44.54M
Accounts Payable	106.44M	99.82M	104.38M	108.10M	67.64M	26.75M	31.16M	22.59M
Short-Term Debt	571.23M	508.98M	464.98M	441.86M	7.96M	0.00	0.00	0.00
Total Liabilities	1.72B	1.33B	1.07B	884.19M	229.13M	172.34M	89.35M	44.54M
Long-Term Debt	452.32M	378.04M	246.13M	102.07M	111.52M	0.00	0.00	0.00
Total Debt	1.02B	887.02M	820.15M	660.76M	238.96M	112.35M	41.09M	0.00
Net Debt (Cash)	300.27M	307.62M	387.30M	184.89M	-269.04M	-601.67M	-630.12M	-318.01M
Total Shareholders' Equity	-191.17M	-109.46M	-160.81M	281.77M	1.01B	1.02B	670.10M	320.51M
Common Stock	9.77M	8.44M	8.55M	8.21M	8.70M	8.82M	7.23M	6.48M
Retained Earnings	-3.17B	-2.65B	-2.51B	-1.99B	-1.41B	-1.26B	-686.05M	-450.13M
Current Ratio	1.04	1.17	0.95	1.29	8.03	14.02	12.74	7.53
Debt to Equity Ratio	N/A	N/A	N/A	2.35	0.24	0.11	0.06	0.00

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

1.30B

1.10B

775.63M

988.06M

917.38M

904.12M

685.87M

335.23M

Cash & Cash Equivalents

723.29M

579.40M

432.85M

475.87M

508.01M

714.03M

671.21M

318.01M

Short-Term Investments

0.00

8.03M

311.02M

268.42M

164.03M

0.00

Cash & Short-Term Investments

723.29M

579.40M

440.88M

786.89M

776.43M

878.06M

671.21M

318.01M

Accounts Receivable

185.15M

172.18M

39.60M

12.74M

2.50M

473K

902K

Inventory

354.03M

306.10M

230.61M

139.81M

85.84M

0.00

Total Assets

1.53B

1.22B

911.24M

1.17B

1.24B

1.20B

759.45M

365.05M

Property, Plant & Equipment

171.98M

102.22M

122.11M

138.12M

143.49M

132.07M

50.58M

4.95M

Goodwill

4.10M

3.62M

3.86M

3.74M

3.98M

4.27M

3.92M

4.00M

Intangible Assets

252K

552K

1.02M

1.43M

2.02M

2.71M

0.00

Long-Term Investments

50.95M

14.06M

6.28M

32.55M

166.09M

152.03M

17.44M

19.55M

Total Current Liabilities

1.26B

940.08M

812.92M

766.91M

114.24M

64.50M

53.86M

44.54M

Accounts Payable

106.44M

99.82M

104.38M

108.10M

67.64M

26.75M

31.16M

22.59M

Short-Term Debt

571.23M

508.98M

464.98M

441.86M

7.96M

0.00

Total Liabilities

1.72B

1.33B

1.07B

884.19M

229.13M

172.34M

89.35M

44.54M

Long-Term Debt

452.32M

378.04M

246.13M

102.07M

111.52M

0.00

Total Debt

1.02B

887.02M

820.15M

660.76M

238.96M

112.35M

41.09M

0.00

Net Debt (Cash)

300.27M

307.62M

387.30M

184.89M

-269.04M

-601.67M

-630.12M

-318.01M

Total Shareholders' Equity

-191.17M

-109.46M

-160.81M

281.77M

1.01B

1.02B

670.10M

320.51M

Common Stock

9.77M

8.44M

8.55M

8.21M

8.70M

8.82M

7.23M

6.48M

Retained Earnings

-3.17B

-2.65B

-2.51B

-1.99B

-1.41B

-1.26B

-686.05M

-450.13M

Current Ratio

1.04

1.17

0.95

1.29

8.03

14.02

12.74

7.53

Debt to Equity Ratio

N/A

2.35

0.24

0.11

0.06

0.00

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)